As noted in Supplemental Table S1, at the annual assessment, subjects with obesity demonstrated significant increases in vaspin (p < 0.05) concentrations and significant decreases in apelin-12 (p < 0.01) concentrations (Figure 1) compared to the initial assessment. This evidence concerns the gene SERPINA12 and obesity disorder.